Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

532 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.
Handunnetti SM, Anderson MA, Burbury KI, Thompson PA, Burke G, Bressel M, Di Iulio JL, Hicks RJ, Westerman DA, Lade S, Pott C, Agarwal R, Koldej RM, Ritchie D, Dreyling M, Dawson MA, Dawson SJ, Seymour JF, Roberts AW, Tam CS. Handunnetti SM, et al. Among authors: thompson pa. Blood. 2024 Apr 25:blood.2023023388. doi: 10.1182/blood.2023023388. Online ahead of print. Blood. 2024. PMID: 38662991
Seven Steps to Financial Health.
Thompson LDR, Thompson PA. Thompson LDR, et al. Among authors: thompson pa. Head Neck Pathol. 2024 Apr 18;18(1):30. doi: 10.1007/s12105-024-01640-7. Head Neck Pathol. 2024. PMID: 38635068
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.
Kittai AS, Bond D, Huang Y, Bhat SA, Blyth E, Byrd JC, Chavez JC, Davids MS, Dela Cruz JP, Dowling MR, Duffy C, Ho C, Jacobson C, Jaglowski S, Jain N, Lin KH, Miller C, McCarthy C, Omer Z, Parry E, Rai M, Rogers KA, Saha A, Schachter L, Scott H, Senapati J, Shadman M, Siddiqi T, Stephens DM, Vanguru V, Wierda W, Woyach JA, Thompson PA. Kittai AS, et al. Among authors: thompson pa. J Clin Oncol. 2024 Mar 29:JCO2400033. doi: 10.1200/JCO.24.00033. Online ahead of print. J Clin Oncol. 2024. PMID: 38552193
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia.
Hampel PJ, Swaminathan M, Rogers KA, Parry EM, Burger JA, Davids MS, Ding W, Ferrajoli A, Hyak JM, Jain N, Kenderian SS, Wang Y, Wierda WG, Woyach JA, Parikh SA, Thompson PA. Hampel PJ, et al. Among authors: thompson pa. Blood Adv. 2024 Mar 27:bloodadvances.2023012080. doi: 10.1182/bloodadvances.2023012080. Online ahead of print. Blood Adv. 2024. PMID: 38537065
Pairing obinutuzumab with venetoclax in relapsed CLL.
Rogers KA, Thompson PA. Rogers KA, et al. Among authors: thompson pa. Leuk Lymphoma. 2024 May;65(5):543-545. doi: 10.1080/10428194.2024.2323682. Epub 2024 Mar 18. Leuk Lymphoma. 2024. PMID: 38497550 No abstract available.
BTK Inhibitors in CLL : Second Generation Drugs and Beyond.
Tam CS, Thompson PA. Tam CS, et al. Among authors: thompson pa. Blood Adv. 2024 Mar 13:bloodadvances.2023012221. doi: 10.1182/bloodadvances.2023012221. Online ahead of print. Blood Adv. 2024. PMID: 38478390
532 results